Myriad Genetics
MYGN
MYGN
252 hedge funds and large institutions have $2.5B invested in Myriad Genetics in 2016 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 91 increasing their positions, 83 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less call options, than puts
Call options by funds: $8.7M | Put options by funds: $26.4M
Holders
252
Holding in Top 10
1
Calls
$8.7M
Puts
$26.4M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$19M | |
| 3 | +$16.1M | |
| 4 |
Millennium Management
New York
|
+$15M |
| 5 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$12.3M |
Top Sellers
| 1 | -$81.5M | |
| 2 | -$39.5M | |
| 3 | -$34.8M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$22.9M |
| 5 |
CIM
Contrarius Investment Management
St. Helier,
Jersey
|
-$15.1M |